Intellectual Property, Patent, Trademark & Copyright Law Updates

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Oct
10
2024
Federal Circuit Finds Evidence of Infringement, Willfulness, and Damages Insufficient as a Matter of Law Barnes & Thornburg LLP
Oct
10
2024
No Matter How You Slice and Dice It, Conclusory Evidence Can’t Support Entire Market Value Damages McDermott Will & Emery
Oct
10
2024
End of an Era: PTO Terminates AFCP 2.0 Amid Fee Concerns McDermott Will & Emery
Oct
10
2024
Got Pillaged? Not If You Didn’t Follow the APA and FTCA McDermott Will & Emery
Oct
10
2024
Federal Circuit Holds Falsely Advertising Product as Patented Can Violate Lanham Act Barnes & Thornburg LLP
Oct
10
2024
CNIPA Releases 2024 National Intellectual Property Service Industry Statistical Survey Report Schwegman, Lundberg & Woessner, P.A.
Oct
7
2024
USPTO Coding Error Affects Patent Term Adjustment: Key Deadlines and Actions for Patentees Barnes & Thornburg LLP
Oct
5
2024
WIPO: China Ranks 11th in Global Innovation Index Schwegman, Lundberg & Woessner, P.A.
Oct
4
2024
SUPER HEROES Fall but SUPER VILLAINS Still Stand Norris McLaughlin P.A.
Oct
3
2024
Chickening Out: Reason for Trademark Abandonment Irrelevant Without Proof of Intent to Resume McDermott Will & Emery
Oct
3
2024
Rewind: Federal Circuit Grants En Banc Rehearing Over Royalty Damages McDermott Will & Emery
Oct
3
2024
No Boundaries? European UPC Confirms Its International Jurisdiction McDermott Will & Emery
Oct
3
2024
Creative License: Fair Use Defense Paints Over Infringement Battle McDermott Will & Emery
Oct
3
2024
It’s a Bird, It’s a Plane—It’s in the Public Domain! USPTO Cancels Marvel and DC Comics’ Trademarks for SUPER HERO and SUPER HEROES Womble Bond Dickinson (US) LLP
Oct
2
2024
Multinational Patent Deal Complications Mintz
Oct
2
2024
Act Quickly to Correct Recent USPTO Patent Term Adjustment Errors Foley & Lardner LLP
Oct
2
2024
USPTO Puts an End to After-Final Pilot Program Foley & Lardner LLP
Oct
1
2024
Streamlining University IP Innovation: How the Improving Efficiency to Increase Competition Act Could Advance University Inventions Proskauer Rose LLP
Oct
1
2024
Fee Changes for Trade Marks and Designs in Australia – Effective 1 October 2024 K&L Gates
Oct
1
2024
Always in Style: Key Considerations in Buying and Selling Fashion Brands Katten
Sep
30
2024
With New Record and Transcribe Tools, Should Employers Be Concerned? Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Sep
30
2024
Your Identity, Your Asset: The Value of Protecting Your Name, Image, and Likeness The National Law Review's Guest Contributors - NLR
Sep
30
2024
Creative License: The Sale and License-Back Structure Appeals to Investors and Brands in the United Kingdom Katten
Sep
30
2024
Stating the Obvious Katten
Sep
27
2024
Dysfunctional Patent Families: The Federal Circuit Draws Two Different Conclusions on Whether a Later-Filed Patent Can Invalidate an Earlier-Filed One in the Same Family Squire Patton Boggs (US) LLP
Sep
27
2024
Taylor Swift and Congress Have “Bad Blood” with AI Deepfakes Proskauer Rose LLP
Sep
26
2024
Dolly Pardon: American Girl Can Sue Foreign Counterfeiter for Internet Sales McDermott Will & Emery
Sep
26
2024
When Can Same Claim Limitation Have Different Meanings? When It’s Functional, Of Course McDermott Will & Emery
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins